Lineage Cell Therapeutics, Inc. Capital Expenditures
Lineage Cell Therapeutics, Inc. (LCTX) reported Capital Expenditures of $163.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- Lineage Cell Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $108.00K, a 671.43% increase year-over-year.
- Lineage Cell Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $55.00K, a 43.30% decline year-over-year.
- Lineage Cell Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $399.00K, a 9.32% increase year-over-year.
- Lineage Cell Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $12.00K, a 89.29% decline year-over-year.
- Lineage Cell Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $522.00K, a 7.61% decline from fiscal 2024.
- Lineage Cell Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $565.00K, a 16.17% decline from fiscal 2023.
- Lineage Cell Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $674.00K, a 63.20% increase from fiscal 2022.
- Lineage Cell Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $413.00K, a 21.47% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $108.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $163.00K 10-Q · filed 2026-08-06 | $562.00K derived: sum of 3 quarters · filed 2026-08-06 | $574.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $55.00K 10-Q · filed 2026-05-12 | $454.00K derived: sum of 2 quarters · filed 2026-05-12 | $466.00K derived: sum of 3 quarters · filed 2026-05-12 | $480.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $399.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $411.00K derived: sum of 2 quarters · filed 2026-03-05 | $425.00K derived: sum of 3 quarters · filed 2026-08-06 | $522.00K 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $26.00K derived: sum of 2 quarters · filed 2026-08-06 | $123.00K 10-Q · filed 2025-11-06 | $488.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $111.00K 10-Q · filed 2026-08-06 | $476.00K derived: sum of 3 quarters · filed 2026-08-06 | $588.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $97.00K 10-Q · filed 2026-05-12 | $462.00K derived: sum of 2 quarters · filed 2026-05-12 | $574.00K derived: sum of 3 quarters · filed 2026-05-12 | $624.00K derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $365.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $477.00K derived: sum of 2 quarters · filed 2026-03-05 | $527.00K derived: sum of 3 quarters · filed 2026-03-05 | $565.00K 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $162.00K derived: sum of 2 quarters · filed 2025-11-06 | $200.00K 10-Q · filed 2025-11-06 | $291.00K derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $88.00K 10-Q · filed 2025-08-12 | $179.00K derived: sum of 3 quarters · filed 2025-08-12 | $318.00K derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $38.00K 10-Q · filed 2025-05-13 | $129.00K derived: sum of 2 quarters · filed 2025-05-13 | $268.00K derived: sum of 3 quarters · filed 2025-05-13 | $524.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $230.00K derived: sum of 2 quarters · filed 2025-03-10 | $486.00K derived: sum of 3 quarters · filed 2025-03-10 | $674.00K 10-K · filed 2025-03-10 | ||||
| 2023-09-30 | $139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $395.00K derived: sum of 2 quarters · filed 2024-11-14 | $583.00K 10-Q · filed 2024-11-14 | $567.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $256.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $444.00K 10-Q · filed 2024-08-08 | $428.00K derived: sum of 3 quarters · filed 2024-08-08 | $714.00K derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $188.00K 10-Q · filed 2024-05-09 | $172.00K derived: sum of 2 quarters · filed 2024-05-09 | $458.00K derived: sum of 3 quarters · filed 2024-05-09 | $555.00K derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $270.00K derived: sum of 2 quarters · filed 2024-03-07 | $367.00K derived: sum of 3 quarters · filed 2024-03-07 | $413.00K 10-K · filed 2024-03-07 | ||||
| 2022-09-30 | $286.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $383.00K derived: sum of 2 quarters · filed 2023-11-09 | $429.00K 10-Q · filed 2023-11-09 | $575.00K derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $97.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $143.00K 10-Q · filed 2023-08-10 | $289.00K derived: sum of 3 quarters · filed 2023-08-10 | $343.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $46.00K 10-Q · filed 2023-05-11 | $192.00K derived: sum of 2 quarters · filed 2023-05-11 | $246.00K derived: sum of 3 quarters · filed 2023-05-11 | $375.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $200.00K derived: sum of 2 quarters · filed 2023-03-09 | $329.00K derived: sum of 3 quarters · filed 2023-03-09 | $340.00K 10-K · filed 2023-03-09 | $354.00K 10-K · filed 2022-03-10 | |||
| 2021-09-30 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $183.00K derived: sum of 2 quarters · filed 2022-11-10 | $194.00K 10-Q · filed 2022-11-10 | $218.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $140.00K 10-Q · filed 2021-08-12 | $164.00K derived: sum of 3 quarters · filed 2022-03-10 | $188.00K derived: sum of 4 quarters · filed 2022-03-10 | ||||
| 2021-03-31 | $11.00K 10-Q · filed 2021-05-13 | $35.00K derived: sum of 2 quarters · filed 2022-03-10 | $59.00K derived: sum of 3 quarters · filed 2022-03-10 | $65.00K derived: sum of 4 quarters · filed 2022-03-10 | ||||
| 2020-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $48.00K derived: sum of 2 quarters · filed 2022-03-10 | $54.00K derived: sum of 3 quarters · filed 2022-03-10 | $64.00K 10-K · filed 2022-03-10 | ||||
| 2020-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $30.00K derived: sum of 2 quarters · filed 2021-08-12 | $40.00K 10-Q · filed 2020-11-04 | $47.00K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $16.00K 10-Q · filed 2021-08-12 | $23.00K derived: sum of 3 quarters · filed 2021-08-12 | $92.00K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $10.00K 10-Q · filed 2021-05-13 | $17.00K derived: sum of 2 quarters · filed 2021-05-13 | $86.00K derived: sum of 3 quarters · filed 2021-05-13 | $281.00K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $76.00K derived: sum of 2 quarters · filed 2021-03-11 | $271.00K derived: sum of 3 quarters · filed 2021-03-11 | $440.00K 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $264.00K derived: sum of 2 quarters · filed 2020-11-04 | $433.00K 10-Q · filed 2020-11-04 | $590.00K derived: sum of 4 quarters · filed 2020-11-04 | ||||
| 2019-06-30 | $195.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $364.00K 10-Q · filed 2020-08-06 | $521.00K derived: sum of 3 quarters · filed 2020-08-06 | $683.00K derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $169.00K 10-Q · filed 2020-05-07 | $326.00K derived: sum of 2 quarters · filed 2020-05-07 | $488.00K derived: sum of 3 quarters · filed 2020-05-07 | $527.00K derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $319.00K derived: sum of 2 quarters · filed 2020-03-12 | $358.00K derived: sum of 3 quarters · filed 2020-03-12 | $556.00K 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | $162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $201.00K derived: sum of 2 quarters · filed 2019-11-12 | $399.00K 10-Q · filed 2019-11-12 | $795.00K derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $237.00K 10-Q · filed 2019-08-08 | $633.00K derived: sum of 3 quarters · filed 2019-08-08 | $1.09M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $198.00K 10-Q · filed 2019-05-09 | $594.00K derived: sum of 2 quarters · filed 2019-05-09 | $1.05M derived: sum of 3 quarters · filed 2019-05-09 | $1.31M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $396.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $852.00K derived: sum of 2 quarters · filed 2019-03-14 | $1.11M derived: sum of 3 quarters · filed 2019-03-14 | $1.33M 10-K · filed 2019-03-14 | ||||
| 2017-09-30 | $456.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $715.00K derived: sum of 2 quarters · filed 2018-11-08 | $930.00K 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | $259.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $474.00K 10-Q · filed 2018-08-02 | ||||||
| 2017-03-31 | $215.00K 10-Q · filed 2018-05-10 | |||||||
| 2016-12-31 | $2.25M 10-K · filed 2018-03-15 | |||||||
| 2016-03-31 | $583.00K 10-Q · filed 2016-05-10 | $1.31M derived: sum of 2 quarters · filed 2018-03-15 | $1.52M derived: sum of 3 quarters · filed 2018-03-15 | $1.75M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2015-12-31 | $727.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $936.00K derived: sum of 2 quarters · filed 2018-03-15 | $1.16M derived: sum of 3 quarters · filed 2018-03-15 | $1.24M 10-K · filed 2018-03-15 | ||||
| 2015-09-30 | $209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $437.00K derived: sum of 2 quarters · filed 2015-11-09 | $514.00K 10-Q · filed 2015-11-09 | $500.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | $228.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $305.00K 10-Q · filed 2015-08-10 | $291.00K derived: sum of 3 quarters · filed 2017-03-16 | $383.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | $77.00K 10-Q · filed 2016-05-10 | $77.01K 10-Q · filed 2015-05-08 | $63.00K derived: sum of 2 quarters · filed 2017-03-16 | $155.00K derived: sum of 3 quarters · filed 2017-03-16 | $328.08K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $78.00K derived: sum of 2 quarters · filed 2017-03-16 | $251.08K derived: sum of 3 quarters · filed 2017-03-16 | $483.00K 10-K · filed 2017-03-16 | $483.10K 10-K · filed 2015-03-11 | |||
| 2014-09-30 | $92.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $265.08K derived: sum of 2 quarters · filed 2015-11-09 | $497.00K 10-Q · filed 2015-11-09 | $497.12K 10-Q · filed 2014-11-07 | $797.96K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-06-30 | $173.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $405.00K 10-Q · filed 2015-08-10 | $404.65K 10-Q · filed 2014-08-11 | $705.96K derived: sum of 3 quarters · filed 2016-03-15 | $1.95M derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-03-31 | $231.92K 10-Q · filed 2015-05-08 | $532.88K derived: sum of 2 quarters · filed 2016-03-15 | $1.77M derived: sum of 3 quarters · filed 2016-03-15 | $2.01M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | $300.96K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $1.54M derived: sum of 2 quarters · filed 2016-03-15 | $1.78M derived: sum of 3 quarters · filed 2016-03-15 | $2.28M 10-K · filed 2016-03-15 | $2.28M 10-K · filed 2014-03-17 | |||
| 2013-09-30 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $1.48M derived: sum of 2 quarters · filed 2014-11-07 | $1.98M 10-Q · filed 2014-11-07 | $2.17M derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-06-30 | $239.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $735.12K 10-Q · filed 2014-08-11 | $930.80K derived: sum of 3 quarters · filed 2015-03-11 | $982.44K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-03-31 | $496.13K 10-Q · filed 2014-05-12 | $691.80K derived: sum of 2 quarters · filed 2015-03-11 | $743.45K derived: sum of 3 quarters · filed 2015-03-11 | $780.34K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2012-12-31 | $195.68K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $247.32K derived: sum of 2 quarters · filed 2015-03-11 | $284.21K derived: sum of 3 quarters · filed 2015-03-11 | $400.81K 10-K · filed 2015-03-11 | ||||
| 2012-09-30 | $51.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $88.53K derived: sum of 2 quarters · filed 2013-11-12 | $205.13K 10-Q · filed 2013-11-12 | $384.89K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-06-30 | $36.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $153.49K 10-Q · filed 2013-08-09 | $333.25K derived: sum of 3 quarters · filed 2014-03-17 | $575.81K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-03-31 | $116.60K 10-Q · filed 2013-05-10 | $296.36K derived: sum of 2 quarters · filed 2014-03-17 | $538.92K derived: sum of 3 quarters · filed 2014-03-17 | $781.10K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2011-12-31 | $179.76K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $422.32K derived: sum of 2 quarters · filed 2014-03-17 | $664.50K derived: sum of 3 quarters · filed 2014-03-17 | $960.28K 10-K · filed 2014-03-17 | ||||
| 2011-09-30 | $242.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $484.74K derived: sum of 2 quarters · filed 2012-11-09 | $780.52K 10-Q · filed 2012-11-09 | $834.85K derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-06-30 | $242.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $537.96K 10-Q · filed 2012-08-09 | $592.28K derived: sum of 3 quarters · filed 2013-03-18 | $613.95K derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-03-31 | $295.79K 10-Q · filed 2012-05-10 | $350.11K derived: sum of 2 quarters · filed 2013-03-18 | $371.78K derived: sum of 3 quarters · filed 2013-03-18 | |||||
| 2010-12-31 | $54.32K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $75.99K derived: sum of 2 quarters · filed 2013-03-18 | $220.77K 10-K · filed 2013-03-18 | |||||
| 2010-09-30 | $21.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $166.45K 10-Q · filed 2011-11-08 | ||||||
| 2010-06-30 | $144.78K 10-Q · filed 2011-08-09 | |||||||
| 2009-12-31 | $61.28K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |